ATE526022T1 - Stabilisierte zusammenstellungen die benzimidazole enthalten - Google Patents
Stabilisierte zusammenstellungen die benzimidazole enthaltenInfo
- Publication number
- ATE526022T1 ATE526022T1 AT99913726T AT99913726T ATE526022T1 AT E526022 T1 ATE526022 T1 AT E526022T1 AT 99913726 T AT99913726 T AT 99913726T AT 99913726 T AT99913726 T AT 99913726T AT E526022 T1 ATE526022 T1 AT E526022T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions containing
- stabilized compositions
- benzimidazole
- type compounds
- containing benzimidazoles
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 abstract 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract 2
- SUUWYOYAXFUOLX-ZBRNBAAYSA-N (2s)-2-aminobutanedioic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N SUUWYOYAXFUOLX-ZBRNBAAYSA-N 0.000 abstract 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salts Chemical class 0.000 abstract 1
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 abstract 1
- 229960002223 arginine aspartate Drugs 0.000 abstract 1
- 229960000913 crospovidone Drugs 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 abstract 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 abstract 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 abstract 1
- 229910000027 potassium carbonate Inorganic materials 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10928898 | 1998-04-20 | ||
| PCT/JP1999/002098 WO1999053918A1 (en) | 1998-04-20 | 1999-04-20 | Stabilized compositions containing benzimidazole-type compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526022T1 true ATE526022T1 (de) | 2011-10-15 |
Family
ID=14506385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99913726T ATE526022T1 (de) | 1998-04-20 | 1999-04-20 | Stabilisierte zusammenstellungen die benzimidazole enthalten |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20020039597A1 (de) |
| EP (1) | EP1004305B1 (de) |
| KR (1) | KR100627614B1 (de) |
| CN (1) | CN1141097C (de) |
| AT (1) | ATE526022T1 (de) |
| CA (1) | CA2298823C (de) |
| ES (1) | ES2373864T3 (de) |
| WO (1) | WO1999053918A1 (de) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| EP1004305B1 (de) * | 1998-04-20 | 2011-09-28 | Eisai R&D Management Co., Ltd. | Stabilisierte zusammenstellungen die benzimidazole enthalten |
| IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
| EP1210091A4 (de) * | 1999-07-12 | 2009-07-29 | Smithkline Beecham Corp | Behandlung von sodbrennen |
| DE60036014T2 (de) | 1999-10-20 | 2008-04-30 | Eisai R&D Management Co., Ltd. | Methode zur stabilisierung von benzimidazol-verbindungen |
| US7396841B2 (en) | 2000-08-18 | 2008-07-08 | Takeda Pharmaceutical Company Limited | Injections |
| WO2002032427A1 (en) * | 2000-10-20 | 2002-04-25 | Galephar M/F | Stable oral formulation containing benzimidazole derivative |
| AR036354A1 (es) * | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | Preparacion solida |
| ES2392960T3 (es) * | 2001-10-17 | 2012-12-17 | Takeda Pharmaceutical Company Limited | Gránulos que contienen gran cantidad de compuesto químico inestable en medio ácido |
| MXPA04004775A (es) * | 2001-11-21 | 2005-02-17 | Eisai Co Ltd | Composicion de preparacion que contiene un compuesto fisiologicamente activo inestable de acido y un proceso para producirlo. |
| AU2002366313A1 (en) * | 2001-12-19 | 2003-06-30 | Takeda Chemical Industries, Ltd. | Solid compositions containng compounds unstable to oxygen and method for stabilization thereof |
| CA2771725C (en) * | 2002-10-16 | 2015-08-18 | Takeda Pharmaceutical Company Limited | Solid preparation comprising a non-toxic base and a proton pump inhibitor |
| MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| JP2006518751A (ja) * | 2003-02-20 | 2006-08-17 | サンタラス インコーポレイティッド | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 |
| US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| WO2004075881A1 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition of rabeprazole and processes for their preparation |
| KR100622638B1 (ko) * | 2003-04-04 | 2006-09-18 | 주식회사 씨트리 | 우수한 안정성을 갖는 란소프라졸 함유 약제학적 조성물및 이의 경구용 제제 |
| US20050042277A1 (en) * | 2003-07-17 | 2005-02-24 | Irukulla Srinivas | Pharmaceutical compositions having a swellable coating |
| TWI398273B (zh) * | 2003-07-18 | 2013-06-11 | Santarus Inc | 用於抑制酸分泌之醫藥調配物及其製備及使用之方法 |
| MXPA06000524A (es) * | 2003-07-18 | 2006-08-11 | Santarus Inc | Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido. |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| WO2005011637A1 (ja) * | 2003-08-04 | 2005-02-10 | Eisai Co., Ltd. | 用時分散型製剤 |
| TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
| US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| CA2547398A1 (en) * | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating |
| EP1718303A4 (de) * | 2004-02-10 | 2010-09-01 | Santarus Inc | Kombination eines protonenpumpenhemmers, puffermittels und einem nichtsteroidalen entzündungshemmenden mittel |
| AU2005249367A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
| US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| CA2614526A1 (en) * | 2005-07-11 | 2006-10-12 | Nycomed Danmark Aps | Benzimidazole formulation |
| EP1801110A1 (de) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Argininsalz des Esomeprazols |
| EP1872778A1 (de) * | 2006-06-29 | 2008-01-02 | LEK Pharmaceuticals D.D. | Stabile pharmazeutische Formulierung enthaltend Rabeprazol-Natrium |
| US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| WO2008129517A2 (en) * | 2007-04-23 | 2008-10-30 | Ranbaxy Laboratories Limited | A stabilized delayed release pharmaceutical composition of rabeprazole |
| EP2293782B1 (de) * | 2008-05-06 | 2015-08-12 | Dexcel Pharma Technologies Ltd. | Stabile benzimidazolformulierung |
| EP2327406A4 (de) * | 2008-08-14 | 2014-04-09 | Kyorin Seiyaku Kk | Stabilisierte pharmazeutische zusammensetzung |
| KR101328383B1 (ko) * | 2009-08-27 | 2013-11-13 | 한림제약(주) | 유럽종 포도의 씨 추출물을 함유하는 경구용 정제 |
| PL2528602T5 (pl) | 2010-01-28 | 2020-09-07 | Eagle Pharmaceuticals, Inc. | Preparaty bendamustyny |
| HRP20240056T1 (hr) | 2012-03-20 | 2024-03-29 | Eagle Pharmaceuticals, Inc. | Formulacije bendamustina |
| CN107157988A (zh) | 2012-03-20 | 2017-09-15 | 赛多斯有限责任公司 | 在要求减少施用容量的患者中治疗苯达莫司汀响应性状况的方法 |
| CN105641702A (zh) * | 2012-04-18 | 2016-06-08 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种雷贝拉唑钠的药用组合物及其制备方法 |
| EP3288556A4 (de) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Oral zerfallende zusammensetzungen |
| CN108347990A (zh) * | 2015-10-16 | 2018-07-31 | 诺维克斯科学私人有限公司 | 维生素c和锌片剂的稳定组合物 |
| WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
| WO2017192728A1 (en) | 2016-05-03 | 2017-11-09 | Virginia Commonwealth University | Heteroatom -doped porous carbons for clean energy applications and methods for their synthesis |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| JP7305560B2 (ja) | 2017-06-12 | 2023-07-10 | グリテック， エルエルシー | Ｎｍｄａアンタゴニスト及びｄ２／５ｈｔ２ａ又は選択的５ｈｔ２ａアンタゴニストによるうつ病の治療 |
| EP3610860A1 (de) * | 2018-08-15 | 2020-02-19 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Zusammensetzung aus kohlendioxidabsorptionsmittel oder -adsorptionsmittel, wobei die besagte zusammensetzung eine aus silikonkautschuk und cellulose ausgewählte polymerbeschichtung enthält |
| KR102315140B1 (ko) * | 2020-01-15 | 2021-10-20 | 주식회사 휴메딕스 | 알지닌 아스파테이트를 포함하는 노인성 체취 억제용 조성물 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| SE8804629D0 (sv) * | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
| YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
| SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
| PT1078628E (pt) | 1994-07-08 | 2009-01-27 | Astrazeneca Ab | Forma de dosagem em comprimidos com unidades múltiplas |
| ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
| SE9500478D0 (sv) | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
| US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
| US5824339A (en) | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
| BE1009764A3 (nl) * | 1995-11-06 | 1997-08-05 | Dsm Nv | Werkwijze voor de bereiding van een alpha-alkylkaneelaldehyde. |
| US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| DE19600347A1 (de) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus |
| JPH09216817A (ja) | 1996-02-08 | 1997-08-19 | Amano Pharmaceut Co Ltd | 防湿性且つ易水崩壊性コーティング製剤 |
| DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
| US5972381A (en) * | 1996-06-28 | 1999-10-26 | Schering Corporation | Solid solution of an antifungal agent with enhanced bioavailability |
| SE9702000D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
| US6296876B1 (en) * | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
| US20050244497A1 (en) * | 1997-11-05 | 2005-11-03 | Wockhardt Limited | Delayed delivery system for acid-sensitive drugs |
| DK173431B1 (da) * | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
| EP1004305B1 (de) * | 1998-04-20 | 2011-09-28 | Eisai R&D Management Co., Ltd. | Stabilisierte zusammenstellungen die benzimidazole enthalten |
| ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| DE60036014T2 (de) * | 1999-10-20 | 2008-04-30 | Eisai R&D Management Co., Ltd. | Methode zur stabilisierung von benzimidazol-verbindungen |
| US20040028737A1 (en) * | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| EP1802118A1 (de) * | 2005-12-23 | 2007-06-27 | Alcatel Lucent | Interaktives Beantwortungssystem für den Zugang für Anwender auf Daten |
-
1999
- 1999-04-20 EP EP99913726A patent/EP1004305B1/de not_active Expired - Lifetime
- 1999-04-20 WO PCT/JP1999/002098 patent/WO1999053918A1/ja not_active Ceased
- 1999-04-20 US US09/462,633 patent/US20020039597A1/en not_active Abandoned
- 1999-04-20 CN CNB998007323A patent/CN1141097C/zh not_active Expired - Fee Related
- 1999-04-20 AT AT99913726T patent/ATE526022T1/de not_active IP Right Cessation
- 1999-04-20 KR KR1019997012021A patent/KR100627614B1/ko not_active Expired - Fee Related
- 1999-04-20 ES ES99913726T patent/ES2373864T3/es not_active Expired - Lifetime
- 1999-04-20 CA CA2298823A patent/CA2298823C/en not_active Expired - Fee Related
-
2004
- 2004-09-13 US US10/938,554 patent/US20050042285A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1004305A1 (de) | 2000-05-31 |
| US20050042285A1 (en) | 2005-02-24 |
| KR100627614B1 (ko) | 2006-09-25 |
| EP1004305A4 (de) | 2009-01-21 |
| US20020039597A1 (en) | 2002-04-04 |
| EP1004305B1 (de) | 2011-09-28 |
| CN1275079A (zh) | 2000-11-29 |
| WO1999053918A1 (en) | 1999-10-28 |
| CN1141097C (zh) | 2004-03-10 |
| CA2298823C (en) | 2011-06-07 |
| ES2373864T3 (es) | 2012-02-09 |
| CA2298823A1 (en) | 1999-10-28 |
| KR20010013994A (ko) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE526022T1 (de) | Stabilisierte zusammenstellungen die benzimidazole enthalten | |
| CY1107506T1 (el) | Μεθοδος για σταθεροποιηση ενωσεων βενζιμιδαζολης | |
| ECSP034613A (es) | Preparacion liofilizada de pantoprazol e inyeccion de pantoprazol | |
| ATE342263T1 (de) | Salze von benzimidazol-derivaten und deren verwendung | |
| ATE219932T1 (de) | Neue feste dosisform enthaltend nanopartikelnaproxen | |
| GB9801690D0 (en) | Therapeutic agents | |
| PE20011122A1 (es) | DERIVADOS DE PURINA-2-ILCARBOXAMIDA COMO AGONISTAS SELECTIVOS DEL RECEPTOR A2a DE LA ADENOSINA | |
| HRP20020198B1 (hr) | Formulacija moksifloksacina i kuhinjske soli | |
| ES2145557T3 (es) | Composiciones de ablandamiento del agua y composiciones detergentes. | |
| ES2151150T3 (es) | Preparados transparentes de rapida liberacion, de analgesicos no esteroidales. | |
| MXPA02012076A (es) | Compuestos quimicos. | |
| BR0109542A (pt) | Derivados de imidazopirina alquilados | |
| BR0208575A (pt) | Dispositivo absorvente para inserção em uma cavidade vaginal | |
| NO20010863D0 (no) | Nye orale formuleringer for 5-HT4-agonister eller - antagonister | |
| ES2079138T3 (es) | Composiciones de limpieza auto-espesantes. | |
| NO994431L (no) | Ny formulering | |
| ES2111083T3 (es) | Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). | |
| ZA200005118B (en) | Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates. | |
| TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| ATE302004T1 (de) | Stabile orale zusammensetzung enthaltend benzimidazol derivate | |
| MXPA03008736A (es) | Derivados de (p-aminohidroxifenil)acrilamida y colorantes que contienen dichos compuestos. | |
| EA200101150A1 (ru) | Раствор прукалоприда для перорального применения | |
| TR200001121T2 (tr) | Antiromatizmal madde. | |
| SE9902742D0 (sv) | New pharmaceutical formultion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |